Improving patient care in severe acute brain injury: a web/mobile/tablet-based communication and decision support tool for clinicians and families in the neuro-ICU

改善严重急性脑损伤患者的护理:为神经重症监护病房的临床医生和家属提供基于网络/移动/平板电脑的通信和决策支持工具

基本信息

项目摘要

Project Summary / Abstract Every 30 seconds an adult in the U.S. suffers a severe acute brain injury (SABI) after a traumatic brain injury, large ischemic stroke or intracerebral hemorrhage, resulting in 200,000 deaths and >900,000 survivors living with disability annually. Every day, surrogate decision makers face the difficult “goals of care” decision in intensive care units (ICUs) to continue or withdraw life support while considering the patient’s long-term prognosis. The stakes for ill-informed goals of care decisions and miscommunications about the prognosis are especially high in patients with SABI; there is the potential for a premature decision leading to the death of a patient who may potentially have survived with a good outcome had treatment been continued, or, conversely, prolongation of life with severe physical and cognitive dysfunction which the patient would not have chosen. In this proposal, we seek to develop a pragmatic, scalable, conceptually grounded intervention to overcome ongoing problems with high stakes decision-making by surrogates of patients with SABI in ICUs. Our long-term goal is to improve the clinical care for SABI patients in neuroICUs by enhancing clinician-family communication and empowering surrogates to make better informed decisions concordant with patient values. To achieve our goal, we will develop a web and mobile/tablet-based intervention for use by surrogates and clinicians (this R21), then test in a multicenter, randomized trial the intervention’s impact on patient outcomes, the quality of surrogate decision- making, families’ psychological outcomes, and health care utilization (subsequent R01). In our previous research we developed a highly usable and acceptable, tailored, paper-based decision aid for families of critically ill SABI patients. Now we plan to widen the tool’s use by leveraging a digital platform, which is more portable and shareable among family members when geographically distant or not allowed to visit the ICU (as during the COVID-19 pandemic) and allows integration of videos to reach lower-literacy groups. We propose a tool that prepares families for their surrogate role and discussions with clinicians; provides balanced information to families on prognosis and all available treatment options; provides tailored information about the patient and family to clinicians in advance of family meetings; and serves as a communication guide for clinicians in the clinician-family meeting. The project’s Specific Aims are to 1) develop an adaptive, user-friendly digital decision aid and communication (DA+C) tool by applying user experience design and eye tracking; 2) assess usability and acceptability of the new DA+C tool; and 3) conduct a pilot study in surrogates of SABI patients at high risk of death and disability to assess the DA+C tool’s feasibility in the ICU and explore its impact on key elements of decision making quality. The research will have high impact as it will yield a rigorously developed intervention and crucial preliminary data needed to conduct a multicenter trial to assess the intervention’s impact on patient, family and health-systems outcomes. The proposed research is innovative through application of user experience design and eye tracking methods. The work is feasible in our hands, as we have the expertise needed, have successfully used all methods proposed here and have obtained buy-in from all relevant clinical services.
项目总结/摘要 在美国,每30秒就有一名成年人在创伤性脑损伤后遭受严重的急性脑损伤(SABI), 大面积缺血性中风或脑内出血,导致20万人死亡,超过90万人幸存, 每年残疾。每一天,代理决策者都面临着艰难的“护理目标”决定, 在考虑患者的长期预后的同时,监护病房(ICU)继续或撤回生命支持。的 护理决策的不知情目标和对预后的误解的风险特别高, SABI患者;有可能过早决定导致患者死亡, 如果继续治疗,或相反,延长生命, 患有严重的身体和认知功能障碍,这是病人不会选择的。在本提案中,我们 寻求制定一个务实的,可扩展的,概念性的干预措施,以克服持续存在的问题, ICU中SABI患者的代理人的高风险决策。我们的长远目标是改善 通过加强临床医生-家属沟通和授权,对神经ICU中的SABI患者进行临床护理 代理人做出更明智的决定与患者的价值观一致。为了实现我们的目标,我们将 开发基于网络和移动的/平板电脑的干预措施,供代理人和临床医生使用(本R21),然后在 多中心随机试验,干预对患者结局的影响,替代决定的质量- 决策、家庭心理结果和卫生保健利用(随后的R 01)。在我们之前的研究中 我们为重症SABI家庭开发了一种高度可用和可接受的、量身定制的纸质决策辅助工具 患者现在,我们计划通过利用数字平台来扩大该工具的使用范围,该平台更具便携性, 当地理位置遥远或不允许访问ICU时,可在家庭成员之间共享(如在 新冠肺炎疫情),并允许整合视频以覆盖识字率较低的群体。我们提出了一种工具, 准备家庭为他们的代理人的作用和讨论与临床医生;提供平衡的信息, 家庭的预后和所有可用的治疗方案;提供有关患者的定制信息, 在家庭会议之前,家庭与临床医生沟通;并作为临床医生的沟通指南, 临床医生家庭会议该项目的具体目标是:1)开发一个自适应的,用户友好的数字决策 通过应用用户体验设计和眼动跟踪,帮助和沟通(DA+C)工具; 2)评估可用性, 新DA+C工具的可接受性; 3)在SABI患者的高风险替代者中进行试点研究, 评估DA+C工具在ICU中的可行性,并探索其对死亡和残疾的关键因素的影响。 决策质量。这项研究将产生很大的影响,因为它将产生一个严格制定的干预措施, 进行多中心试验以评估干预措施对患者、家庭、 和卫生系统的成果。该研究通过用户体验的应用是创新的 设计和眼动跟踪方法。这项工作在我们手中是可行的,因为我们有所需的专业知识, 成功地使用了这里提出的所有方法,并获得了所有相关临床服务的认可。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susanne Muehlschlegel其他文献

Susanne Muehlschlegel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susanne Muehlschlegel', 18)}}的其他基金

Improving Clinical Decisions for Critically Ill Traumatic Brain Injury Patients
改善危重脑外伤患者的临床决策
  • 批准号:
    9304870
  • 财政年份:
    2015
  • 资助金额:
    $ 25.58万
  • 项目类别:
Improving Clinical Decisions for Critically Ill Traumatic Brain Injury Patients
改善危重脑外伤患者的临床决策
  • 批准号:
    8967750
  • 财政年份:
    2015
  • 资助金额:
    $ 25.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了